Viewing Study NCT04653493


Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2025-12-25 @ 11:12 PM
Study NCT ID: NCT04653493
Status: UNKNOWN
Last Update Posted: 2021-03-19
First Post: 2020-11-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
Sponsor: Sabz Biomedicals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module